Handelsbanken Fonder AB - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 247 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.

Quarter-by-quarter ownership
Handelsbanken Fonder AB ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$1,300,000
-86.2%
8,600
-86.7%
0.01%
-85.2%
Q2 2022$9,413,000
-71.5%
64,600
-76.8%
0.06%
-66.8%
Q1 2022$33,034,000
-16.5%
278,600
-3.0%
0.18%
-5.6%
Q4 2021$39,565,000
+2.6%
287,100
+3.4%
0.20%
-3.5%
Q3 2021$38,561,000
+35.7%
277,600
-5.1%
0.20%
+36.5%
Q2 2021$28,406,000
+55.3%
292,600
+9.3%
0.15%
+42.3%
Q1 2021$18,290,000
-8.3%
267,600
+15.0%
0.10%
-14.0%
Q4 2020$19,936,000
+13.8%
232,600
-13.7%
0.12%
-5.5%
Q3 2020$17,520,000
-51.0%
269,500
-44.8%
0.13%
-15.8%
Q2 2020$35,722,000
+325.0%
488,600
+97.8%
0.15%
-16.0%
Q1 2020$8,405,000
-39.9%
247,000
-3.9%
0.18%
-25.2%
Q4 2019$13,991,000
+44.6%
257,000
+10.8%
0.24%
+23.5%
Q3 2019$9,679,000
+45.4%
232,000
+52.6%
0.20%
+59.3%
Q2 2019$6,656,000152,0000.12%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q4 2020
NameSharesValueWeighting ↓
RP Management, LLC 1,111,111$107,867,00052.60%
Knoll Capital Management, LLC 856,844$83,182,00043.44%
ORACLE INVESTMENT MANAGEMENT INC 2,082,555$202,174,00027.86%
ARS Investment Partners, LLC 558,286$54,198,0005.52%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 176,400$17,113,0004.52%
KINGDON CAPITAL MANAGEMENT, L.L.C. 401,006$38,930,0004.51%
Eventide Asset Management 1,990,797$193,267,0002.60%
SILVERARC CAPITAL MANAGEMENT, LLC 56,626$5,497,0002.45%
Avidity Partners Management LP 882,500$85,673,0002.32%
Nicholas Investment Partners, LP 363,708$35,309,0002.22%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders